Chris Mason

Chris Mason may refer to:

*Chris Mason (actor), (born 1991), English actor *Chris Mason (artist) (born 1976), Australian artist * Chris Mason (darts player) (born 1969), English darts player * Chris Mason (footballer) (born 1986), English footballer * Chris Mason (ice hockey) (born 1976), Canadian ice hockey player * Chris Mason (journalist) (born 1980), English journalist * Chris Mason (musician), American musician * Chris Mason (runner), winner of the 1969 distance medley relay at the NCAA Division I Indoor Track and Field Championships Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Chris Mason', query time: 0.03s Refine Results
  1. 1
    Gene Therapy Developments for Pompe Disease

    Gene Therapy Developments for Pompe Disease by Zeenath Unnisa, John K. Yoon, Jeffrey W. Schindler, Chris Mason, Niek P. van Til

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene

    Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene by Sadfer Ali, Milena Rivera, John Ward, Eli Keshavarz-Moore, Chris Mason, Darren N. Nesbeth

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Trimethoprim‐sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation

    Trimethoprim‐sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation by Matthew Donnan, Miranda Siemienowicz, Hui Sien Tay, Catriona McLean, Steve Philpot, Chris Mason, Greg Snell, Ian Glaspole, Rob G. Stirling

    Published 2024-07-01
    Get full text
    Article
  4. 4
    An autonucleolytic suspension HEK293F host cell line for high-titer serum-free AAV5 and AAV9 production with reduced levels of DNA impurity

    An autonucleolytic suspension HEK293F host cell line for high-titer serum-free AAV5 and AAV9 production with reduced levels of DNA impurity by Geoffrey Howe, Mehtap Bal, Matt Wasmuth, Giulia Massaro, Ahad A. Rahim, Sadfer Ali, Milena Rivera, Desmond M. Schofield, Aminat Omotosho, John Ward, Eli Keshavarz-Moore, Chris Mason, Darren N. Nesbeth

    Published 2024-09-01
    Get full text
    Article
  5. 5
    Screening chimeric GAA variants in preclinicalstudy results in hematopoietic stem cell genetherapy candidate vectors for Pompe disease

    Screening chimeric GAA variants in preclinicalstudy results in hematopoietic stem cell genetherapy candidate vectors for Pompe disease by Yildirim Dogan, Cecilia N. Barese, Jeffrey W. Schindler, John K. Yoon, Zeenath Unnisa, Swaroopa Guda, Mary E. Jacobs, Christine Oborski, Tim Maiwald, Diana L. Clarke, Axel Schambach, Richard Pfeifer, Claudia Harper, Chris Mason, Niek P. van Til

    Published 2022-12-01
    Get full text
    Article

Search Tools: